Evolent Health, Inc.
EVH
$7.57
$0.121.61%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.40B | 2.55B | 2.46B | 2.35B | 2.18B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.40B | 2.55B | 2.46B | 2.35B | 2.18B |
| Cost of Revenue | 2.03B | 2.19B | 2.07B | 1.92B | 1.73B |
| Gross Profit | 365.72M | 367.35M | 393.27M | 437.01M | 447.36M |
| SG&A Expenses | 258.28M | 250.35M | 248.14M | 267.85M | 290.32M |
| Depreciation & Amortization | 112.93M | 118.37M | 118.68M | 121.38M | 123.64M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.40B | 2.56B | 2.44B | 2.31B | 2.14B |
| Operating Income | -5.49M | -1.37M | 26.45M | 47.78M | 33.40M |
| Income Before Tax | -109.47M | -63.04M | -87.18M | -94.30M | -130.95M |
| Income Tax Expenses | -508.00K | -1.41M | -14.95M | -19.88M | -20.61M |
| Earnings from Continuing Operations | -108.96 | -61.62 | -72.23 | -74.42 | -110.34 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -108.96M | -61.62M | -72.23M | -74.42M | -110.34M |
| EBIT | -5.49M | -1.37M | 26.45M | 47.78M | 33.40M |
| EBITDA | 125.55M | 135.12M | 119.23M | 142.96M | 130.74M |
| EPS Basic | -1.22 | -0.81 | -0.91 | -0.94 | -1.25 |
| Normalized Basic EPS | -0.47 | -0.13 | 0.02 | 0.11 | -0.02 |
| EPS Diluted | -1.22 | -0.81 | -0.91 | -0.94 | -1.25 |
| Normalized Diluted EPS | -0.47 | -0.13 | 0.02 | 0.11 | -0.02 |
| Average Basic Shares Outstanding | 459.90M | 458.72M | 457.28M | 454.70M | 451.29M |
| Average Diluted Shares Outstanding | 459.90M | 458.72M | 457.28M | 454.70M | 451.29M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -17.97% | -32.59% | -28.30% | -27.42% | -18.33% |